Medicamen Biotech Limited (BOM:531146)

Medicamen Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	436.79	37.59	147.86	207.79	38.25	38.91
Cash & Short-Term Investments	436.79	37.59	147.86	207.79	38.25	38.91
Cash Growth	580.89%	-74.57%	-28.84%	443.26%	-1.69%	25.80%
Accounts Receivable	775.71	689	552.59	652.58	632.24	525.47
Other Receivables	-	246.2	223.43	219.83	196.18	225.22
Receivables	802.38	935.2	776.03	872.41	828.42	750.69
Inventory	687.68	621.37	593.75	450.57	270.1	52.04
Prepaid Expenses	-	1.72	1.57	0.65	7.35	4.26
Other Current Assets	307.28	49.62	76.73	102.21	86.26	114.43
Total Current Assets	2,234	1,645	1,596	1,634	1,230	960.33
Property, Plant & Equipment	849.77	863.62	909.52	917.59	921.18	894.35
Other Intangible Assets	6.59	7.42	8.98	8.98	3.6	2.04
Long-Term Deferred Tax Assets	29.62	28.3	25.15	18.8	4.96	-2.83
Long-Term Deferred Charges	430.85	414.22	393.73	195.12	88.17	75.6
Other Long-Term Assets	39.52	12.45	12.19	11.07	8.65	7.75
Total Assets	3,671	2,972	2,946	2,785	2,257	1,937
Accounts Payable	431.83	348.17	334.57	416.52	393.12	274.34
Accrued Expenses	8.13	97.48	68.45	53.3	37.81	51.37
Short-Term Debt	350.31	295.19	295.62	233.13	192.75	109.29
Current Portion of Long-Term Debt	-	5.21	2.94	15.26	14.47	14.86
Current Income Taxes Payable	48.91	33.24	40.63	37	42.64	46
Current Unearned Revenue	-	-	3.18	21.31	14.41	4.75
Other Current Liabilities	16.67	2.33	100.17	49.22	31.71	32.13
Total Current Liabilities	855.86	781.62	845.55	825.74	726.91	532.74
Long-Term Debt	36.17	37.34	12.56	8.7	50.74	64.05
Pension & Post-Retirement Benefits	-	17.77	14.63	13.16	10.98	9.27
Long-Term Deferred Tax Liabilities	0.01	-0.03	-	-	-	-
Other Long-Term Liabilities	24.94	4.27	2.93	3.45	3.62	2.28
Total Liabilities	916.99	840.98	875.67	851.03	792.24	608.34
Common Stock	135.63	127.15	127.15	126.51	122.17	122.17
Additional Paid-In Capital	-	1,023	1,023	978.73	677.05	677.04
Retained Earnings	-	963.08	907.67	825.38	687.82	551.07
Comprehensive Income & Other	2,618	5.21	-7.01	-12.14	-22.34	-21.39
Total Common Equity	2,754	2,119	2,051	1,918	1,465	1,329
Minority Interest	-	11.98	18.92	15.66	-	-
Shareholders' Equity	2,754	2,131	2,070	1,934	1,465	1,329
Total Liabilities & Equity	3,671	2,972	2,946	2,785	2,257	1,937
Total Debt	386.49	337.74	311.12	257.09	257.96	188.19
Net Cash (Debt)	50.31	-300.15	-163.26	-49.3	-219.71	-149.29
Net Cash Per Share	4.14	-23.61	-12.90	-3.90	-17.98	-12.22
Filing Date Shares Outstanding	17.09	12.71	12.71	12.65	12.22	12.22
Total Common Shares Outstanding	17.09	12.71	12.71	12.65	12.22	12.22
Working Capital	1,378	863.88	750.38	807.89	503.47	427.59
Book Value Per Share	161.11	166.62	161.30	151.65	119.89	108.78
Tangible Book Value	2,748	2,111	2,042	1,910	1,461	1,327
Tangible Book Value Per Share	160.72	166.04	160.60	150.94	119.60	108.61
Land	-	9.42	9.42	9.42	9.42	9.42
Buildings	-	374.91	373.19	371.88	370.28	341.95
Machinery	-	985.95	966.94	907.24	853.66	798.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.